Overview
The life sciences industry is characterized, in large part, by unending innovation driven by the constant demand for new medical therapies. It is equally characterized by a robust but evolving regulatory framework in which the development of new technologies tends to outpace the laws needed to govern them.
In such a dynamic environment dominated by compliance issues and enforcement concerns, savvy legal advice is essential to an organization’s success.
At Epstein Becker Green, we have a tight-knit team of life sciences attorneys and advisors with strong backgrounds in science, industry, and government. Our clients are often on the leading edge of new technologies, and they trust us to guide them in areas where the regulatory picture remains unclear. We help them understand the law and its practical implications so they can adopt workable approaches to their legal, regulatory, and business issues.
Navigating the Regulatory Landscape
In an industry where stringent compliance obligations accompany every facet of a product’s development and commercialization, few companies can navigate the regulatory landscape without help. Our clients look to us to devise an overall regulatory strategy for their product, and we work with them to decide how that strategy will be implemented. How and by whom will the therapy be used? What research will be needed? What claims will need substantiating? What reimbursement schemes make the most sense? The answers to such questions—and countless similar ones—form the basis of each application for regulatory approval and provide our clients with roadmaps for addressing compliance issues going forward.
Our deep understanding of the applicable regulatory bodies and their enforcement mechanisms is key to every aspect of our client service. We represent clients in front of all such bodies, both in routine matters and in investigative inquiries. Our lawyers advise them on the development of their manufacturing and distribution systems. We arrange contracts defining their relationships with customers, vendors, and payors. We review their pricing options and sign off on advertising and promotional communications. Each of these efforts—and much more—is designed to ensure that all operations are fully optimized from both a business and a regulatory standpoint.
Serving Our Clients
Our team of life sciences attorneys and advisors serves organizations across the length and breadth of the life sciences industry, including:
- Academic centers
- Artificial intelligence companies
- Biotechnology companies
- Clinical laboratories
- Combination product manufacturers
- Digital health (IoT) companies
- Food and Dietary Supplements
- Genetics and Genomics
- Human cellular and tissue products (HCT/P) manufacturers
- In vitro diagnostic innovators
- Investors in the life sciences industry
- Medical device manufacturers
- Pharmaceutical and biologic manufacturers
- Precision medicine laboratories
- Research institutions and investigators
- Research services vendors (including contract research organizations and site management organizations
- Suppliers and distributors
- Telehealth companies
- Trade associations and industry coalitions
We cover a broad scope of products and services that fall within these general categories: research and development, clinical research support, product commercialization, FDA regulatory strategy, compliance and training, litigation, and transactions and capitalization.
Read less
Focus Areas
Services
- Academic and Clinical Research
- ADA and Public Accommodations
- Affirmative Action/OFCCP Compliance
- Appellate
- Business Torts, Competition & Trade Secrets
- Class Actions
- Commercial and Contract Litigation
- Corporate & Transactional
- Corporate and Securities Litigation
- Corporate Compliance Program Development, Implementation, and Effectiveness
- Corporate Financing
- Corporate Governance
- Corporate Reorganization
- Cross-Border Data Transfers
- Cross-Border Transactions
- Cybersecurity Risk Assessment
- Data Asset Management
- Data Breach and Incident Response
- Data Breach/Cybersecurity Investigations & Litigation
- Data Protection
- Dietary Supplement Litigation
- Digital Health
- Diversity, Equity & Inclusion Counseling
- Drug and Medical Device Coding, Coverage, and Payment
- Drug and Medical Device Distribution
- Drug and Medical Device Litigation
- Drug Pricing Policy & Reporting
- Employee Benefits and ERISA
- Employment Compliance Counseling
- Employment Litigation
- Employment Training
- Employment, Labor & Workforce Management
- ERISA – Retirement and Benefit Plan Litigation
- Executive Compensation
- FDA Inspections and Enforcement
- Federal Research Grants: Compliance, Investigations & Enforcement
- Financial Restructuring and Bankruptcy
- Foreign Multinational Counseling and Litigation
- General Counsel Services
- Health Care
- Health Care and Life Sciences Investigations and Enforcement
- Health Care and Life Sciences Investor Services
- Health Policy and Legislation
- Immigration
- Industry Research and Clinical Trials
- Insider Threats
- Intellectual Property
- Intellectual Property Litigation
- Internet of Things (IoT)
- Labor and Employment Due Diligence
- Labor Management Relations
- Life Sciences
- Life Sciences Due Diligence
- Litigation & Business Disputes
- Mergers, Acquisitions & Divestitures
- Occupational Safety and Health (OSHA)
- Pandemic Workforce Issues
- Pay Equity
- Privacy Compliance Strategies
- Privacy, Cybersecurity & Data Asset Management
- Product Marketing and Compliance
- Ransomware
- Real Estate
- Regulatory Strategy, Product Development, and Product Approvals
- Remote and Hybrid Work
- Social Media and the Workplace
- State Privacy Law Compliance
- Tax and Tax-Exempt Counseling
- Trade Secrets & Employee Mobility
- Wage and Hour
- Whistleblowing and Compliance
- White Collar Defense and Internal Investigations
- Workforce Government Relations
- Workforce Restructuring and Other Cost-Saving Mechanisms
- Workplace Investigations
Industries
Trending Issues
Experience
Our Team
Media
Events
Upcoming Events
Past Events
- December 10-11, 2024
Insights
Insights
- Media CoverageRichard Hughes Quoted in “ACA Suit Threatens Overhaul of Preventive Care in Employer Plans”2 minute read
- BlogsDOJ’s False Claims Act Recoveries Top $2.9 Billion in FY 2024, but Health Care Numbers Dip—What Could FY 2025 Hold for ...4 minute read
- Media CoverageGeorge Breen Quoted in “DOJ Secured $1.7B from Healthcare False Claims Settlements, Judgments in 2024”5 minute read
- Media CoverageRichard Hughes Quoted in “How RFK Jr. Drove Mistrust of a Cancer Prevention Vaccine”7 minute read
- BlogsRecent Developments in Health Care Cybersecurity and Oversight: 2024 Wrap Up and 2025 Outlook6 minute read
- Media CoverageRichard Hughes Quoted in “Supreme Court Case Offers Trump Path to Dismantle Obamacare Mandates”5 minute read
- BlogsVideo: PAGA in California, NLRB Authority, New Employment Laws in 2025 - Employment Law This Week3 minute read
- Media CoverageRichard Hughes Quoted in “Supreme Court to Hear ACA Preventive Coverage Suit”4 minute read
- Media CoverageRichard Hughes Quoted in “Supreme Court to Hear ACA Preventive Care Case”1 minute read
- Media CoverageRichard Hughes Quoted in “Biden Admin Finalizes NBPP, MA Pay Rules Ahead of Departure”2 minute read
- Media CoverageRichard Hughes Quoted in “SCOTUS to Review ACA’s Free Preventative Services Mandate”2 minute read
- BlogsSecond Circuit Adopts “At Least One Purpose” Rule for False Claims Act Cases Premised on Anti-Kickback Statute ...8 minute read
- Media CoverageThomas Jaworski Featured in “Acting U.S. Attorney Joins Epstein Becker Green”1 minute read
- Media CoverageThomas Jaworski Featured in “On the Move”2 minute read
- Media CoverageRichard Hughes Quoted in “Obamacare Case Presents Renewed Opportunity to Restrict Agencies”4 minute read
- Media CoverageChristopher Coyne Quoted in “Key Factors to Consider in Return-to-Exempt Status Decisions”3 minute read
- PublicationsTop Ten Issues in Health Law 2025—Gender Affirming Care: 2025 Outlook4 minute read
- BlogsVideo: Employment Law in 2025: A Look Ahead - Employment Law This Week4 minute read
- Media Coverage
Glenn Prives Featured in AHLA’s Speaking of Health Law Podcast, “Corporate Practice of Medicine: Latest Trends and ...
2 minute read - Firm AnnouncementsEpstein Becker Green Adds Acting U.S. Attorney for the Middle District of Tennessee Thomas Jaworski3 minute read
- Media CoverageRichard Hughes Quoted in “RFK Jr. Could Reshape Vaccine Injury Program, Add Autism”2 minute read
- Media CoverageGeorge Breen Featured in “Medtech 2025: Deregulation, Tariffs Anticipated from New US Administration”3 minute read
- Media CoverageGeorge Breen Featured in “Medtech 2025: ‘Moving Forward, No Matter What’”3 minute read
- Media CoverageMark Lutes Quoted in “What's Keeping Mid-Law Leaders Up at Night in 2025”2 minute read
- Media CoverageRichard Hughes Quoted in “5 Cases Benefits Attorneys Should Keep an Eye On in 2025”2 minute read
- Media CoverageBradley Merrill Thompson Quoted in “FDA's Device Center Vigorously Stirred the Regulatory Pot in 2024”2 minute read
- PublicationsEnforcement of CTA Halted Yet Again After Federal Court Reverses Course and Reinstates Nationwide Injunction2 minute read
- Media CoverageMegan Robertson Quoted in “FDA Wrapped: Prominent Guidance from 2024”2 minute read
- PublicationsCTA Revived: Corporate Transparency Act Injunction Lifted by Federal Court and Filing Deadlines Extended3 minute read
- Media CoverageCourtney McFate Featured in “People on the Move”1 minute read
- Media CoverageRishi Puri Featured in “People on the Move”1 minute read
- PublicationsNext Year's Legal Buzz: What’s Brewing for Oregon and Washington Employers in 202510 minute read
- PublicationsPreparing for 2025: New Laws and Workplace Posting Requirements for New Jersey Employers19 minute read
- PublicationsIllinois Employers Need to Know Nine New Employment Laws for 202522 minute read
- PublicationsCalifornia 2025: The Next Wave of New Employer Compliance Obligations Is About to Hit20 minute read
- BlogsVideo: 2024 Workforce Review - Top Labor and Employment Law Trends and Updates - Employment Law This Week4 minute read
- BlogsUnpacking Averages: Exploring Data on FDA’s Breakthrough Device Program Obtained Through FOIA14 minute read
- Firm Announcements
Four Epstein Becker Green Attorneys Named to the 2025 Ohio Super Lawyers List
2 minute read - Media CoverageGary Herschman Quoted in “Consolidation Continues Despite Hurdles in Private Equity”4 minute read
- PublicationsPaid Sick Leave Is Coming to Alaska, Missouri, and Nebraska in 202512 minute read
- BlogsSpilling Secrets Podcast: 2024’s Biggest Trade Secrets and Non-Compete Developments2 minute read
- Media CoverageJames Boiani Quoted in “Supplement Makers Try to Latch On to GLP-1 Boom”2 minute read
- PublicationsEnforcement of Corporate Transparency Act Halted by Federal Court3 minute read
- PublicationsMedicare Coverage of Antiobesity Medicines1 minute read
- PublicationsHealthcare M&A Insights: Q3 2024 & End-of-Year Outlook2 minute read
- Media CoverageBradley Merrill Thompson Quoted in “FDA’s Final PCCP Guidance Clarifies Expectations for AI Submissions”2 minute read
- Media CoverageRichard Hughes Featured in “‘How Far Will RFK Go?’ 2 Experts Talk Kennedy’s Potential Impact on Child Health” ...4 minute read
- Media CoveragePhilo Hall Quoted in “A Medicare Minefield Awaits Oz”2 minute read
- Firm AnnouncementsEpstein Becker Green Awards 2024 Annual Core Values Champions5 minute read
- BlogsVideo: Biden’s Final Labor Moves - Employment Law This Week4 minute read